S&P Dow Jones announced today that it will remove the Aveo Group
(ASX:AOG) from the S&P/ASX 200, subject to final court approval of the scheme of arrangement whereby the company will be acquired by Brookfield Asset Management.
Aveo investors have vote to sell the company to the Canadian investment firm for $2 billion.
Aveo Group will be replaced by Avita Medical
(ASX:AVH) in the S&P/ASX 200 effective at the open on November 14, 2019.
Shares in Aveo Group
(ASX:AOG) closed 0.47 per cent lower at $2.14 yesterday.
